Background. The Long QT Syndrome (LQTS) is an infrequently occurring familial disorder in which affected individuals have electrocardiographic QT interval prolongation and a propensity to veiltricular tachyarrhythmic syncope and sudden death. We prospectively investigated the clinical characteristics and the long-term course of 3,343 individuals from 328 families in which one or more members were identified as affected with LQTS (QTc>0.44
sec"12).
Methods and Results. The first member of a family to be identified with LQTS, the proband, was usually brou,ght to medical attention because of a syncopal episode during childhood or teenage years. Probands (n=328) were younger at first contact (age 21±+15 years), more likely to be female (69%o), and had a higher frequency of preenroilment syncope or cardiac arrest with resuscitation (80%), congenital deafness (7%), a resting heart rate less than 60 beats/min (31%), QTc.0.50 sec"2 (52%), and a history of ventricular tachyarrhythmia (47%) than other affected (n=688) and unaffected (n=1,004) family members. Arrhythmogenic syncope often occurred in association with acute physical, emotional, or auditory arousal. The syncopal episodes were frequently misinterpreted as a seizure disorder. By age 12 years, 50% of the probands had experienced at least one syncopal episode or death. The rates of postenrollment syncope (one or more episodes) and probable LQTS-related death (before age 50 years) for probands (n=235; average follow-up 54 months per patient) were 5.0% per year and 0.9% per year, respectively; these event rates were considerably higher than those observed among affected and unaffected family members.
Conclusions. Among 232 probands and 1,264 family members with prospective follow-up, three factors made significant independent contributions to the risk of subsequent syncope or probable LQTS-related death before age 50 years, whichever occurred first (Cox hazard ratio; 95% confidence limits): 1) QTc (1.052; 1.017, 1.088), 2) history of cardiac event (3.1; 1.3, 7.2), and 3) heart rate (1.017; 1.004, 1.031). The findings from this prospective longitudinal study highlight the clinical features, risk factors, and course of LQTS. (Circulation 1991;84:1136-1144) T he idiopathic long QT syndrome (LQTS) is an infrequently occurring disorder in which affected individuals have an unusual electrocardiographic repolarization abnormality (QT prolongation) and a propensity to syncope and fatal ventricular arrhythmias.1,2 The genetics of the syn-drome are not completely understood, but autosomal dominant3,4 and autosomal recessive5,6 modes of inheritance are suggested by the pattern of occurrence of this disorder in families. In addition, sporadic cases without familial involvement occasionally occur. This disorder primarily affects children and young adults with structurally normal hearts. The lethality of the condition in terms of the development of life-threatening ventricular tachyarrhythmias, including torsades de pointes, may be quite variable among affected individuals. Antiadrenergic therapy with ,B-blocking drugs7 and/or left cervicothoracic sympathetic ganglionectomy89 is usually prescribed to prevent recurrent syncope and cardiac death in symptomatic patients with LQTS. Sympathetic ganglionectomy may be effective in preventing recurrent syncope that is refractory to medical management.10 Permanent cardiac pacing has been used to prevent bradycardia-dependent ventricular tachyarrhythmias and syncope in this disorder.1'
Beginning in 1979, our research group established an international, prospective, longitudinal study of patients affected with LQTS. The purpose of this ongoing investigation is to elucidate the clinical aspects of this disorder. A preliminary report of the first 196 patients with LQTS enrolled in this program was published in 1985.12 To date, we have enrolled 3,343 individuals from 328 families in which one or more members were identified as having LQTS. The clinical findings and long-term course of this population are the subject of this report.
Methods

Identification of Probands
Physicians who were caring for patients with suspected LQTS contacted one of the LQTS physicianinvestigators at our internationally dispersed clinical centers (Rochester, N.Y.; Charlottesville, Va.; Salt Lake City, Utah; Houston, Tex.; Milan, Italy; and Jerusalem, Israel) for consultation advice regarding diagnosis and management of their patient. The referring physician was queried regarding the occurrence of syncope or cardiac arrest and the use of prescription medication in the patient under consideration, and a prospectively designed data form was filled out. A 12-lead electrocardiogram was forwarded to the LQTS physician-investigator, and the QT and R-R intervals were measured in lead II (lead I or III if the QT interval was not measurable in lead II). The observed QT interval was corrected for heart rate (QTc) according to Bazett's formula, 13 where QTc is in the peculiar time dimension sec"12. The first living referred patient identified independently of relatives with OTc>0.44 was defined as the proband and served as the index case (propositus) for family evaluation. Index patients receiving medication known to prolong the QT interval were excluded from enrollment.
Population
As of July 1, 1990, 328 
Follow-up
For each individual enrolled in the study we attempted to gather yearly follow-up clinical information through phone or mail contact with the individual and by contact with the identified personal physician to evaluate the patient's clinical course and medication usage. Sixty-four percent of the follow-up information was obtained from the patient or family member, 32% from the attending physician, and 4% from other sources.
End Points
Syncopal events (fainting spell with transient loss of consciousness) and deaths identified during pedigree construction and during follow-up were specifically recorded. The logistics of this international study did not permit an independent, uniform review of all the terminal events. However, family members were queried about the clinical circumstances surrounding the death of their relative as to the presence or absence of preexisting medical problems and the chronological abruptness of the terminal event.
Unexpected, sudden (abruptly and without warning as described by the family), natural death before age 50 years, exclusive of a known cause, was categorized as a probable LQTS-related death. Age 50 years was used as an arbitrary cut-off to exclude older patients whose death might be due to more common cardiovascular disorders such as coronary disease.
Data Management and Analysis
Clinical data were recorded on prospectively designed forms and included demographic, historical, family history, electrocardiographic, therapeutic, and follow-up information. Quality control procedures were in place throughout the study to ensure internal consistency of the recorded data on printed data forms and to minimize missing data when they could be retrieved. Family pedigrees were constructed by a trained geneologist with a master's degree in genetics. The study electrocardiograms were interpreted by four physicians, and all R-R and QT intervals were rechecked by a second physician. The study data were maintained in a relational database system (INGRES) on a Digital Equipment Corporation (VAX 8350) computer. The reported analyses used the analytic database released July 1, 1990. tIncludes nonsustained or sustained ventricular tachycardia, torsades de pointes, or ventricular fibrillation documented on an electrocardiogram or Holter recording before enrollment. Only 89 probands and 79 affected family members had Holter recordings performed before enrollment. §Electrocardiographic findings on the first recorded tracing.
The cumulative age-related probability of experiencing a first known cardiac event (syncope or probable LQTS-related death, whichever occurred first) using both birth and enrollment date as the time origin was determined for the various subgroups of the population using the life-table method of Kaplan and Meier. 14 The joint contribution of pertinent variables from enrollment to the occurrence time of first follow-up cardiac events was analyzed by the Cox proportional hazards regression model.15 Analyses were carried out on the total population stratified into probands and family members; separate proband and family member analyses were also performed. The analyses identified the risk factors that made an independent contribution to the Cox model. Treatment factors were then added to the risk factor model one at a time to evaluate the contribution that each of these therapies made to the full model. The contributions of identified factors to outcome cardiac events are presented in terms of the hazard ratio, the risk of having an outcome event per unit of time during follow-up for each extra unit of the risk factor. Attempts were made to identify any clustering effects within families; if nothing significant was found, family members were then analyzed without regard to the identifying proband.
Results
Population Characteristics
The pertinent clinical characteristics of the 328 probands, the 688 affected, and 1,004 unaffected family members are presented in Table 1 . The population was nearly equally divided between those with QTc>0.44 (n=1,016) and those with QTc.0.44 (n = 1,004). The probands were younger, more likely to be female, and had a higher frequency of prior cardiac tPremortem electrocardiogram interpreted as normal but postmortem review revealed these QTc values. Note: Recurrent syncopal episodes in this group of patients were considered to be seizure disorders by the attending physicians despite normal electroencephalograms. events (syncope or cardiac arrest with resuscitation), congenital deafness, bradycardia, QTc2 0.50, and ventricular tachyarrhythmia than the affected and unaffected family members. Eighty-five percent of the probands had one or more family members with QTc>0.44. Only 10% of the probands had no family members with QTc>0.44 and no family history of syncope or death before age 50 years. This small group of probands might represent the so-called sporadic form of LQTS.
Almost 80% of the probands were receiving ,3-blocking medication at the time of enrollment, and 12% already had left cervicothoracic sympathetic ganglionectomy. Among those with available information about factors associated with syncopal events prior to enrollment, 47% (77 of 163) of the patients had one or more syncopal episodes occurring in association with intense emotions (anger or fright), 41% (68 of 165) with vigorous physical activity exclusive of swimming, 19% (32 of 166) on awakening, 15% (21 of 143) while swimmning, and 8% (14 of 166) on arousal by auditory stimuli such as the ringing of an alarm clock or a telephone or the sound of thunder. Misdiagnosis During the course of this 10-year prospective follow-up study, we became aware of several LQTS pa-tients in whom the diagnosis of LQTS was missed despite unexplained recurrent syncope. The pertinent findings in 10 representative patients misdiagnosed as benign syncope or seizure disorder are presented in Table 2 . These patients were, in fact, experiencing arrhythmogenic syncope, and the correct diagnosis of LQTS was established only after a tragic cardiac arrest occurred in a family member or when an electrocardiogram was fortuitously obtained on the patient for some unrelated reason. On a few occasions, an electrocardiogram had been taken earlier but QT prolongation was not appreciated by the physician interpreting the tracing. Once the diagnosis of LQTS was established, a family history of premature sudden cardiac death or unexplained syncope, or both, extending back a generation or two, became quite obvious.
Mortality Events
In the LQTS study population, 147 patients died before age 50 years. One hundred eight patients identified retrospectively during family pedigree construction had little if any clinical information available other than age at death, gender, and whether or not the patient had ever been treated for LQTS before death; in the remaining 39 patients, clinical Antiadrenergic therapy* (%) (n=116) 9 *Antiadrenergic therapy includes fl-blocker medication at any time in the past and/or left cervicothoracic sympathetic ganglionectomy.
information including an electrocardiogram was available. The clinical characteristics of patients on whom recorded data are available are presented in Table 3 . Mortality events occurred predominantly in young patients (57% by age 20 years) who had a history of syncope and marked QT prolongation but were not receiving antiadrenergic therapy. The cumulative age-related probability of experiencing a first known cardiac event (syncope or probable LQTS-related death) from birth until age 50 years is presented in Figure 1 for the entire LQTS population subdivided into probands and affected, unaffected, and undetermined family members. The probands were usually identified after a syncopal event, and this partly explains the high probability of experiencing a cardiac event in this group compared with the other groups. In the undetermined group, the identified events were probable LQTS-related deaths, as no information was available regarding possible preceding syncope. By age 12 years, 50% of the probands, 8% of the affected family members, and 2% of undetermined and unaffected family members experienced a first cardiac event.
The cumulative probability of experiencing a follow-up cardiac event (syncope or probable LQTSrelated death) after enrollment for probands and the affected and unaffected family members is presented in Figure 2 . After 10 years of follow-up, 37% of the probands, 5% of the affected family members, and less than 1% of the unaffected family members had experienced a cardiac event. Prospective Follow-up Follow-up information was obtained on 235 probands, 549 affected family members, and 756 unaffected family members. The clinical characteristics, therapy, and cardiac event rates for each of the three groups are presented in Table 4 . The rates of syncope and death for probands were considerably higher than those observed among affected and unaffected family members. In addition, probands with a history of a cardiac event before enrollment had more than twice the rate of syncope during follow-up than did probands with a negative prior history (5.5 versus 2.6 syncopal events per year). The death rates during follow-up were similar in the two proband subgroups. Of note, among the probands with follow-up events, a majority (84%) were receiving /-blockers at the time of the latest recorded event. In those with events, the QTc was quite prolonged in the probands and the affected family members.
The clinical, electrocardiographic, and treatment characteristics of the 12 affected family members and the three unaffected family members who developed cardiac events during the prospective follow-up after enrollment are presented in Table 5 . One half of the patients had a prior cardiac event, and 29% were receiving /3-blockers. Separate Cox regression survival analyses were carried out for: 1) the entire population, stratified into probands and family members, 2) the probands, and 3) the affected and unaffected family members. These time-dependent analyses used enrollment as the time origin and first follow-up cardiac events (syncope or probable LQTS-related death, whichever occurred first) for the end points. The findings from the three analyses are presented in Table 6 . For the entire study population, three risk variables were identified: QTc, history of a cardiac event, and heart rate ( Table 6 ). For the probands, two risk variables were identified: QTc and heart rate ( Table 6 ). For the family members, the risk variables were history of a cardiac event and female gender ( Table 6 ). For continuous variables, the hazard ratio is expressed per unit increase in the value of the variable. Thus, a proband with QTc=0.60 would have a 2.2-fold greater risk of having a follow-up cardiac event per unit of time than a proband with QTc=0.45 (hazard ratio= 1.05515=2.2). Since there were no interactions in any of the models, the hazard ratios in each model in Table 6 permit quantification of the joint risk when two or more factors coexist. The combined risk is simply the product of the hazard ratios of the coexisting factors. For example, a proband with QTc=0.60 and a heart rate of 80 beats/min would have a 3.2-fold greater risk of having a follow-up cardiac event than a proband with QTc=0.45 and a heart rate of 60 beats/min (combined hazard ratio= 1.05515 x 1.01820=3.2). Of note, none of the treatment factors (/3-blockers, left cervicothoracic sympathetic ganglionectomy, or pacemakers) made a significant contribution to any of the three risk factor models. 
Discussion
This prospective long-term follow-up study of patients with LQTS indicates that this disorder is largely familial (85% of probands had family members with QTc>0.44) with variable severity of expression among those with QTc>0.44. The first member of a family to be identified with LQTS, the proband, was usually brought to the attention of the medical profession because of a syncopal episode during childhood or teenage years. Probands had a more malignant course than the secondarily identified affected family members in terms of syncope and death, both retrospectively using birth as the time origin and prospectively after enrollment in this study.
The findings from the Cox survival analyses (Table  6 ) are of interest. Different risk variables were iden- (1.1, 15 ) *Other baseline variables (congenital deafness, repetitive ventricular arrhythmias, family history of death before age 50 years, and age at enrollment) and interaction effects were dropped from the models (p>0.10). None of the treatment factors (j-blockers, left cervicothoracic sympathetic ganglionectomy, or pacemakers) made significant contributions to any of the three risk factor models.
tRatio of the risk of experiencing a cardiac event (syncope or probable long QT syndrome-related death before age 50 years, whichever occurred first) per unit time during follow-up for patients with the factor to those without the factor. For continuous variables, the hazard ratio is expressed per unit increase in the value of the variable. tified in the separate analyses performed on the probands and on the family members. The reason for this is unclear, but it may relate to the fact that 84% of the probands were receiving some form of LQTS therapy at enrollment, whereas only 20% of family members were under treatment. In the entire population and in the proband group, QTc and heart rate were significant risk factors. That is, patients with longer QTc and faster heart rates were at greater risk of having events than patients with shorter QTc and slower heart rates. This is the first time that the duration of QTc has been identified as a risk factor in LQTS, and it makes sense with what we know about this disorder. Heart rate as a risk factor is more difficult to explain. It may be that the patients with slower heart rates were receiving ,B-blockers, and this therapy may provide protection even though 13-blockers did not enter the Cox models as a beneficial factor. Patients not receiving ,3-blockers and young children would surely have faster heart rates, and both these factors may be masked by the heart rate variable.
We used the conventional definition of a pro- 10 representative LQTS patients in whom the occurrence of syncopal episodes before enrollment in this study were misinterpreted as a seizure disorder (Table 2) . Several tragic outcomes have resulted from this error in diagnosis. Our database does not permit us to quantitate the overall frequency of this problem in the study population. However, misdiagnosis is not an infrequent occurrence in this relatively rare disorder. Several articles describing this phenomenon have been published,18-21 but the potentially fatal consequences of missing the diagnosis of LQTS in patients with syncope are still not adequately appreciated by practicing physicians. An electrocardiogram with careful analysis and measurement of QT and QTc intervals should be included in the workup of all patients with unexplained syncope.
We cannot answer the question of the efficacy of ,B-blocker therapy, surgical left cervicothoracic sympathetic ganglionectomy, or pacemakers in the management of this population of patients with LQTS. This investigation was designed as an observational study, and we did not control the therapy rendered to individual patients. None of these therapies was identified in the univariate or multivariate analyses as showing a significant beneficial effect on outcome. However, the high use of ,8-blockers (78%) and the low frequency of ganglionectomy or pacemakers (12-13%) in the probands compromise the power of detecting a clear-cut effect with any of these therapies. More important, therapy was generally used in patients perceived to be at higher risk. This current investigation of 328 LQTS families involving 1,016 patients with OTc>0.44 extends our earlier findings on the 196 LQTS patients reported in 1985. Syncope continues to be associated with acute physical, emotional, or auditory arousal. Historical data regarding syncope and ventricular ectopy remain important risk factors for subsequent cardiac events. In our earlier study,12 females had a borderline significant increased risk of experiencing a cardiac event relative to males (relative risk 2.2, 95% confidence interval 1.0, 4.8); an increased risk for females was seen among family members in the current study (relative risk 3.9, 95% confidence interval 1.1, 15 ). The current rates of syncope (5.0% per year) and cardiac death (0.9% per year) for the probands are somewhat less than those reported in the earlier study (8.6% per year and 1.3% per year, respectively). These reductions in event rates may reflect the ongoing enrollment of patients with less severe forms of LQTS as suggested by Schwartz, 22 possibly a beneficial effect from the increased use of antiadrenergic therapy during the past 5 years (78% of the probands were on ,B-blockers at the time of enrollment; Table 1 ), or both.
There are several limitations inherent in this observational study of a probable genetic disorder. An ascertainment bias was present in that we required the probands to be alive at the time of enrollment. In genetic studies, probands are identified by a phenotypic characteristic whether they are alive or dead at the time of ascertainment.23 The probands were usually brought to the attention of the LQTS study because of a major cardiac event, and this would certainly bias the reporting of cumulative cardiac events in favor of the probands as presented in Figure 1 . Selection bias probably also accounts for the increased proband event rate after enrollment because LQTS patients frequently experience multiple episodes of syncope. Although LQTS predominantly affects the younger age group, only one of our nine physician-investigators was a pediatric cardiologist. Thus, there was probably an inadvertent selection bias in favor of older probands. Follow-up information was available on only 76% of the probands and family members. The missing follow-up information contributes to an incomplete data set with some reduced precision in the quantitated event rates and the risk factor hazard ratios. Despite these limitations, this prospective longitudinal study of LQTS patients and family members is the largest yet reported with this disorder. The findings from this study enhance our understanding of the natural history and the clinical features of this familial, prolonged repolarization syndrome.
